Revision of USP Chapter <541> Titrimetry
Recommendation

Monday, 21 September 2026 14.00 - 16.00 h
Regulatory Landscape: ECHA, USP, Pharmacopoeias and FDA Enforcement
In the Pharmacopeial Forum, PF 48(5), a revision of USP chapter <541> Titrimetry is being proposed. The proposal is based on the version of the chapter official prior to 2013.
The chapter was previously divided into the following main sections:
- Direct titrations
- Residual titrations
- Complexometric titrations
- Oxidation-reduction (Redox) titrations
- Titrations in nonaqueros solvents
- Indicator and potentiometric endpoint detection
- Blank corrections
- Introduction
- Types of titrations
- Materials and equipment
In addition, besides minor editorial changes, the following updates are mentioned in the briefing notes:
- "Incorporate most of the currently official chapter information into the revised chapter in corresponding sections with the same section titles, if applicable.
- Replace Table 1 and Table 2 with information provided under Types of Titrations and Materials and Equipment.
- Add Automated Titration and Standardization of Titrants to provide current information regarding modern titrimetry processes."
The draft of the revised chapter is available on PF Online. Comments can be submitted until November 30, 2022.
Related GMP News
03.09.2026USP Article: Supporting the Detection of Asbestos in Pharmaceutical Talc
02.09.2026USP Publishes Comments Received on Chapter <320>
26.08.2026New USP Requirements for Asbestos Testing in Pharmaceutical Talc
19.08.2026FDA Warning Letter: Averaging Data to Override OOS Findings
12.08.2026ECA's Analytical Control Group Publishes Detailed Report on OOS Survey
12.08.2026BP Publishes Key Insights on Limits in Chromatographic Tests


